For U.S. Medicare Advantage plans, retrospective risk adjustment involves reviewing historical charts for supported diagnoses, missed codes, and codes that should be withdrawn.
We ranked five AI-assisted options by evidence traceability and review controls, with RAAPID first for that use case.
RAAPID is our top pick for evidence-centered review with human coding decisions.
Datavant suits plans combining chart retrieval and coding with one vendor.
Reveleer pairs source-linked suggestions with required coder confirmation.
Cotiviti supports NLP-assisted additions-and-deletions review and coder tracking.
Optum offers in-house coding software and coding services.
We reviewed public documentation and accessible third-party evidence as of October 12, 2026. We did not test products, interview customers, or access software.
This ranking reflects documented fit, not measured accuracy.
Our criteria were evidence traceability, two-way correction, human review and quality assurance, retrieval and integration fit, and commercial transparency.
Comparable public pricing and complete independent ratings were unavailable.
Correction controls matter after DOJ's March 11, 2026 announcement of Aetna's $117.7 million settlement of allegations involving inaccurate diagnoses and failures to withdraw them.
The settlement resolves allegations; it is not a judicial finding.

RAAPID pros
Links HCC codes to chart evidence and identifies unsupported codes
Prioritizes chart-chase lists and centralizes audit tracking
Offers clinical APIs and custom API development
Describes separate RADV audit workflows with certified-auditor expertise
RAAPID cons
Public pricing requires a scoped proposal
Confirm API and audit components included in your contract
Why we picked RAAPID
We put RAAPID first for evidence traceability because its HCC-to-evidence links make coding suggestions reviewable.
RAAPID's Retrospective Risk Adjustment guide provides useful background on reviewing historical charts, documenting coding decisions, and considering supported additions and unsupported-code removals.
The guide describes human coders confirming or rejecting AI suggestions.
It is vendor-published background, not official guidance, independent validation, or proof of package entitlements. KLAS's May 20, 2026 spotlight has a gated dataset; we report no grade.
RAAPID pricing
Public pricing not listed; request a scoped proposal. We would assess value against included review work and confirm API and audit-tool scope.

Datavant pros
NLP compares chart codes with prior coding results
First-pass coding, additional reviews, and tiered quality checks
Published network: 80,000+ hospitals and clinics; 20,000+ digital FHIR connections
Datavant cons
Scope retrieval, technology, and review services separately
Network totals do not guarantee your connections
Why we picked Datavant
We picked Datavant for plans where chart acquisition and coding quality checks both need attention.
Comparing extracted codes with previous results gives reviewers a starting point for discrepancy review. We would verify which connections serve the plan's actual providers.
Datavant is the 2026 Best in KLAS winner for risk-adjustment coding, retrieval and compliance, scoring 90.5/100. This performance score is not a measure of AI coding accuracy.
Datavant pricing
Public pricing not listed; request a scoped proposal. Ask for retrieval, coding technology, and review services to be itemized.

Reveleer pros
Shows the source excerpt and page for each suggested code
Requires coder confirmation
Provides chase prioritization and project dashboards
Reveleer cons
Coder confirmation requires staffing capacity
The published customer result covers one plan, not a service-level commitment
Why we picked Reveleer
We picked Reveleer for its source-linked review workflow. Reviewers can examine the cited chart passage before confirming a suggestion, while managers track projects through dashboards.
Reveleer reports that a health plan coded 1.2M charts in 4 months, according to Reveleer's customer case study.
That undated, vendor-published case study describes a single health plan, not an independently audited benchmark or a throughput promise for other customers.
Reveleer pricing
Public pricing not listed; request a scoped proposal. Clarify the retrieval and coding work included before comparing costs.

Cotiviti pros
NLP and machine learning review clinical and claims data
Prioritizes evidence with confidence scoring
Highlights additions and deletions
Tracks coder productivity and accuracy
Cotiviti cons
Confirm scope separately from adjacent Cotiviti services
Validate connections to your existing systems
No independent product rating verified in this review
Why we picked Cotiviti
We picked Cotiviti for internal teams comparing clinical and claims information.
Its documented two-way review covers supported additions and unsupported-code deletions, a capability shared with other options here.
Confidence scoring and coder tracking support review prioritization and management oversight, a pattern that mirrors how AI-enabled SaaS is reshaping wider healthcare operations.
We would ask how reviewers resolve conflicting evidence and record their decisions.
During demonstrations, we would also ask vendors to distinguish the confidence score from the final coding decision.
Cotiviti pricing
Public pricing not listed; request a scoped proposal. Specify the retrospective software and any separately quoted services.

Optum pros
In-house SaaS coding option
Coding and review services
AI combines clinical knowledge, NLP, and contextual methods
Integration within Optum's risk-adjustment platform
Optum cons
Public materials describe a product family, not comparable self-service tiers
Connections outside Optum's platform need confirmation
Why we picked Optum
We picked Optum for plans deciding who will do the coding work. Its documentation describes both in-house software and coding services, so buyers can compare operating models.
Confirm external-system requirements separately rather than assuming the published platform integration covers your existing environment.
We would ask each proposal to identify who reviews suggestions, handles exceptions, and owns final coding decisions.
We found no eligible independent rating for this retrospective product; our assessment remains qualitative.
Optum pricing
Public pricing not listed; request a scoped proposal. Compare software-only and service-supported scopes if both fit your plan.
RAAPID is our top pick for U.S. Medicare Advantage teams prioritizing evidence-traceable review.
Before selecting it, ask for a demonstration with de-identified supported, unsupported, and ambiguous diagnoses, and confirm the contracted scope.
Shortlist Datavant for combined retrieval and coding, Reveleer for source-linked confirmation, Cotiviti for internal discrepancy review, or Optum for software-versus-services decisions.
Compare correction handling, evidence records, and scoped costs. Your team retains final coding responsibility; ask how each workflow records those decisions.